Logo image of CVE-PR-B.CA

CENOVUS ENERGY INC - CVECN 4.14 PERP (CVE-PR-B.CA) Stock Fundamental Analysis

Canada - TSX:CVE-PR-B - CA15135U4063

24.24 CAD
+0.44 (+1.85%)
Last: 10/2/2025, 7:00:00 PM
Fundamental Rating

5

Overall CVE-PR-B gets a fundamental rating of 5 out of 10. We evaluated CVE-PR-B against 212 industry peers in the Oil, Gas & Consumable Fuels industry. CVE-PR-B has only an average score on both its financial health and profitability. CVE-PR-B is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CVE-PR-B had positive earnings in the past year.
CVE-PR-B had a positive operating cash flow in the past year.
Of the past 5 years CVE-PR-B 4 years were profitable.
Each year in the past 5 years CVE-PR-B had a positive operating cash flow.
CVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

With a decent Return On Assets value of 4.74%, CVE-PR-B is doing good in the industry, outperforming 77.36% of the companies in the same industry.
CVE-PR-B has a better Return On Equity (9.01%) than 64.62% of its industry peers.
CVE-PR-B's Return On Invested Capital of 6.17% is fine compared to the rest of the industry. CVE-PR-B outperforms 76.42% of its industry peers.
CVE-PR-B had an Average Return On Invested Capital over the past 3 years of 11.92%. This is significantly above the industry average of 6.85%.
The 3 year average ROIC (11.92%) for CVE-PR-B is well above the current ROIC(6.17%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.74%
ROE 9.01%
ROIC 6.17%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE-PR-B.CA Yearly ROA, ROE, ROICCVE-PR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

CVE-PR-B has a Profit Margin of 5.13%. This is comparable to the rest of the industry: CVE-PR-B outperforms 55.19% of its industry peers.
CVE-PR-B's Profit Margin has declined in the last couple of years.
The Operating Margin of CVE-PR-B (7.37%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CVE-PR-B has grown nicely.
CVE-PR-B has a Gross Margin (31.62%) which is comparable to the rest of the industry.
CVE-PR-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.37%
PM (TTM) 5.13%
GM 31.62%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE-PR-B.CA Yearly Profit, Operating, Gross MarginsCVE-PR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CVE-PR-B is creating some value.
The number of shares outstanding for CVE-PR-B has been reduced compared to 1 year ago.
Compared to 5 years ago, CVE-PR-B has more shares outstanding
CVE-PR-B has a worse debt/assets ratio than last year.
CVE-PR-B.CA Yearly Shares OutstandingCVE-PR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE-PR-B.CA Yearly Total Debt VS Total AssetsCVE-PR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CVE-PR-B has an Altman-Z score of 2.47. This is not the best score and indicates that CVE-PR-B is in the grey zone with still only limited risk for bankruptcy at the moment.
CVE-PR-B has a better Altman-Z score (2.47) than 72.64% of its industry peers.
The Debt to FCF ratio of CVE-PR-B is 3.52, which is a good value as it means it would take CVE-PR-B, 3.52 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.52, CVE-PR-B belongs to the top of the industry, outperforming 84.43% of the companies in the same industry.
CVE-PR-B has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, CVE-PR-B perfoms like the industry average, outperforming 56.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.52
Altman-Z 2.47
ROIC/WACC0.8
WACC7.73%
CVE-PR-B.CA Yearly LT Debt VS Equity VS FCFCVE-PR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

CVE-PR-B has a Current Ratio of 1.32. This is a normal value and indicates that CVE-PR-B is financially healthy and should not expect problems in meeting its short term obligations.
CVE-PR-B's Current ratio of 1.32 is fine compared to the rest of the industry. CVE-PR-B outperforms 67.92% of its industry peers.
CVE-PR-B has a Quick Ratio of 1.32. This is a bad value and indicates that CVE-PR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CVE-PR-B has a Quick ratio (0.78) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.78
CVE-PR-B.CA Yearly Current Assets VS Current LiabilitesCVE-PR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

5

3. Growth

3.1 Past

CVE-PR-B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.82%.
Measured over the past years, CVE-PR-B shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.97% on average per year.
Looking at the last year, CVE-PR-B shows a decrease in Revenue. The Revenue has decreased by -7.82% in the last year.
Measured over the past years, CVE-PR-B shows a very strong growth in Revenue. The Revenue has been growing by 21.88% on average per year.
EPS 1Y (TTM)-43.82%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-15.09%
Revenue 1Y (TTM)-7.82%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-17.24%

3.2 Future

The Earnings Per Share is expected to grow by 23.27% on average over the next years. This is a very strong growth
CVE-PR-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.67% yearly.
EPS Next Y-1.37%
EPS Next 2Y-2.47%
EPS Next 3Y13.54%
EPS Next 5Y23.27%
Revenue Next Year-8.75%
Revenue Next 2Y-6.1%
Revenue Next 3Y-4.67%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVE-PR-B.CA Yearly Revenue VS EstimatesCVE-PR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
CVE-PR-B.CA Yearly EPS VS EstimatesCVE-PR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.19, the valuation of CVE-PR-B can be described as rather expensive.
Based on the Price/Earnings ratio, CVE-PR-B is valued a bit cheaper than the industry average as 63.21% of the companies are valued more expensively.
CVE-PR-B's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.91.
The Price/Forward Earnings ratio is 15.54, which indicates a correct valuation of CVE-PR-B.
CVE-PR-B's Price/Forward Earnings is on the same level as the industry average.
CVE-PR-B is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.19
Fwd PE 15.54
CVE-PR-B.CA Price Earnings VS Forward Price EarningsCVE-PR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CVE-PR-B's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CVE-PR-B is cheaper than 83.49% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVE-PR-B indicates a somewhat cheap valuation: CVE-PR-B is cheaper than 67.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.56
EV/EBITDA 5.83
CVE-PR-B.CA Per share dataCVE-PR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The decent profitability rating of CVE-PR-B may justify a higher PE ratio.
CVE-PR-B's earnings are expected to grow with 13.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.51
EPS Next 2Y-2.47%
EPS Next 3Y13.54%

More info and screens

5

5. Dividend

5.1 Amount

CVE-PR-B has a Yearly Dividend Yield of 3.43%.
CVE-PR-B's Dividend Yield is a higher than the industry average which is at 6.78.
Compared to an average S&P500 Dividend Yield of 2.44, CVE-PR-B pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.43%

5.2 History

On average, the dividend of CVE-PR-B grows each year by 31.72%, which is quite nice.
CVE-PR-B has paid a dividend for at least 10 years, which is a reliable track record.
CVE-PR-B has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)31.72%
Div Incr Years3
Div Non Decr Years3
CVE-PR-B.CA Yearly Dividends per shareCVE-PR-B.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CVE-PR-B pays out 52.38% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CVE-PR-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP52.38%
EPS Next 2Y-2.47%
EPS Next 3Y13.54%
CVE-PR-B.CA Yearly Income VS Free CF VS DividendCVE-PR-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE-PR-B.CA Dividend Payout.CVE-PR-B.CA Dividend Payout, showing the Payout Ratio.CVE-PR-B.CA Dividend Payout.PayoutRetained Earnings

More info and screens

CENOVUS ENERGY INC - CVECN 4.14 PERP

TSX:CVE-PR-B (10/2/2025, 7:00:00 PM)

24.24

+0.44 (+1.85%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners51.38%
Inst Owner ChangeN/A
Ins Owners0.67%
Ins Owner ChangeN/A
Market Cap43.32B
Analysts80
Price Target26.02 (7.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.43%
Yearly Dividend0.84
Dividend Growth(5Y)31.72%
DP52.38%
Div Incr Years3
Div Non Decr Years3
Ex-Date09-15 2025-09-15 (0.27562)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.63%
Min EPS beat(2)25.67%
Max EPS beat(2)177.6%
EPS beat(4)2
Avg EPS beat(4)31.19%
Min EPS beat(4)-72.97%
Max EPS beat(4)177.6%
EPS beat(8)4
Avg EPS beat(8)15.06%
EPS beat(12)6
Avg EPS beat(12)3.89%
EPS beat(16)8
Avg EPS beat(16)-6.48%
Revenue beat(2)0
Avg Revenue beat(2)-4.79%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)-4.15%
Revenue beat(4)1
Avg Revenue beat(4)-4.06%
Min Revenue beat(4)-10.43%
Max Revenue beat(4)3.8%
Revenue beat(8)4
Avg Revenue beat(8)-0.2%
Revenue beat(12)6
Avg Revenue beat(12)3.13%
Revenue beat(16)10
Avg Revenue beat(16)5.12%
PT rev (1m)-14.59%
PT rev (3m)-15.8%
EPS NQ rev (1m)16.36%
EPS NQ rev (3m)-18.84%
EPS NY rev (1m)-2.8%
EPS NY rev (3m)-7.49%
Revenue NQ rev (1m)4%
Revenue NQ rev (3m)-5.86%
Revenue NY rev (1m)2.51%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 17.19
Fwd PE 15.54
P/S 0.84
P/FCF 14.56
P/OCF 5.29
P/B 1.47
P/tB 1.64
EV/EBITDA 5.83
EPS(TTM)1.41
EY5.82%
EPS(NY)1.56
Fwd EY6.44%
FCF(TTM)1.66
FCFY6.87%
OCF(TTM)4.58
OCFY18.91%
SpS28.88
BVpS16.45
TBVpS14.81
PEG (NY)N/A
PEG (5Y)0.51
Profitability
Industry RankSector Rank
ROA 4.74%
ROE 9.01%
ROCE 7.82%
ROIC 6.17%
ROICexc 6.51%
ROICexgc 6.95%
OM 7.37%
PM (TTM) 5.13%
GM 31.62%
FCFM 5.76%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexcg growth 3Y-0.51%
ROICexcg growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.52
Debt/EBITDA 1.14
Cap/Depr 105.59%
Cap/Sales 10.11%
Interest Coverage 250
Cash Conversion 93.66%
Profit Quality 112.35%
Current Ratio 1.32
Quick Ratio 0.78
Altman-Z 2.47
F-Score4
WACC7.73%
ROIC/WACC0.8
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.82%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-15.09%
EPS Next Y-1.37%
EPS Next 2Y-2.47%
EPS Next 3Y13.54%
EPS Next 5Y23.27%
Revenue 1Y (TTM)-7.82%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-17.24%
Revenue Next Year-8.75%
Revenue Next 2Y-6.1%
Revenue Next 3Y-4.67%
Revenue Next 5YN/A
EBIT growth 1Y-45.73%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year99.31%
EBIT Next 3Y27.11%
EBIT Next 5Y17.19%
FCF growth 1Y-34.2%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y-6.52%
OCF growth 3Y15.98%
OCF growth 5Y22.96%